A) The lack of potential applications. B) The uncontroversial ethical implications. C) The ease of obtaining stem cells from adults. D) The use of embryonic stem cells.
A) Ethical guidelines and regulations. B) Ignoring public opinions and concerns. C) Speed of research progress above all else. D) Funding from private corporations only.
A) To eliminate competition among research institutions. B) To address regulatory disparities and ensure ethical standards. C) To hinder progress in the field. D) To avoid sharing scientific breakthroughs.
A) Excluding patient advocates from the research process. B) Creating financial barriers to stem cell research. C) Developing international policy guidance on stem cell research. D) Promoting unregulated stem cell experimentation.
A) Replace traditional medicine for all illnesses. B) Repair, replace, and regenerate damaged cells or tissues. C) Speed up the aging process in patients. D) Create artificial intelligence using stem cells.
A) To only focus on economic factors. B) To ignore public opinions and concerns. C) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. D) To prioritize scientific progress over societal implications.
A) Serving as decision-makers for all stem cell research projects. B) Opposing all forms of medical research involving stem cells. C) Advocating for unrestricted research with no ethical oversight. D) Providing expertise on ethical implications and considerations.
A) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. B) There is no difference between the two types of stem cells. C) Pluripotent cells are more versatile than totipotent cells. D) Pluripotent cells can only divide a limited number of times. |